16 Minutes #58: The Johnson & Johnson Vaccine and COVID Efficacy Rates
In today’s episode of our news analysis show 16 Minutes, our topic is the ongoing buzz and the mixed news around the Johnson & Johnson vaccine, which was the third vaccine for COVID approved under Emergency Use Authorization by the FDA just a few weeks ago. Johnson & Johnson reported it as “the first single...
Raghu Raghurama16z.com
The Little Tech Agendaa16z.com
Engaging the Unengaged at Home with Max Cohen and Cameron Behara16z.com
Evolve or Die: The Future of the Creative Process, Artist Authenticity, and the Value of the Musica16z.com
The State of AI & Educationa16z.com
America's Energy Problem: The Grid That Built America Can’t Power Its Futurea16z.com
Lessons Swift Designer Chris Lattner Has Learned about LeadershipThenewstack
The rise of slow personal assistantsCerebras
A Big Chip for Big Science: Watching the COVID-19 Virus in Action - CerebrasCerebras
Maximize Sales with Ecommerce Video StrategiesHeygen
How to 3x response rates with AI videoSynthesia
Learning in the Flow of Work: How to Design for ImpactSynthesia
Supply Chain Attack on Axios Pulls Malicious Dependency from npmSocket
Fast Static Sites with Netlify and AnyModCss Tricks
National Energy Technology Laboratory and Pittsburgh Supercomputing Center Pioneer First EverCerebras
Measuring CI/CD Adoption Rates Is a ProblemThenewstack
DuckDB Tutorial for Beginners: Installation to First QueryMotherduck
Faster health data analysis with MotherDuck & PreswaldMotherduck
AI notetakers beyond transcription: How leading companies turn meetings into measurable businessAssemblyai
100 million people now use NotionNotion So
